The Emergence of the Metabolic Syndrome with Menopause
The DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index.
Abstract
Women with the metabolic syndrome (central obesity, insulin resistance, and dyslipidemia) are known to be at especially high risk for cardiovascular disease (CVD). The prevalence of the metabolic syndrome increases with menopause and may partially explain the apparent acceleration in CVD after menopause. The transition from pre- to postmenopause is associated with the emergence of many features of the metabolic syndrome, including 1) increased central (intraabdominal) body fat; 2) a shift toward a more atherogenic lipid profile, with increased low density lipoprotein and triglycerides levels, reduced high density lipoprotein, and small, dense low density lipoprotein particles; 3) and increased glucose and insulin levels. The emergence of these risk factors may be a direct result of ovarian failure or, alternatively, an indirect result of the metabolic consequences of central fat redistribution with estrogen deficiency. It is unclear whether the transition to menopause increases CVD risk in all women or only those who develop features of the metabolic syndrome. This article will review the features of the metabolic syndrome that emerge with estrogen deficiency. A better understanding of these metabolic changes with menopause will aid in the recognition and treatment of women at risk for future CVD, leading to appropriate interventions.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Disturbances of this metabolic signal lead to the development of metabolic syndrome and a higher cardiovascular risk in women.”
From Estrogen deficiency and the origin of obesity during menopause (2014) · cites this paper as [31]
Citations
Cites
3 retracted
Changes in energy balance and body composition at menopause: a controlled longitudinal study.
Poehlman, E. T., Toth, M. J., & Gardner, A. W. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-123-9-199511010-00005 · Cited by 520 · cited 4×
“Several groups have shown increased fasting insulin (22, 48) and increased fasting glucose levels (37, 63) in postmenopausal compared with premenopausal women, which would imply worsened insulin resistance with the menopause.”
BackgroundInfluentialRetractedMenopause, energy expenditure, and body composition
Poehlman, É. T. (2002) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1034/j.1600-0412.2002.810705.x · Cited by 144 · cited 1×
“Menopause is also associated with reduced lean body mass (muscle) and this appears to be related to decreased physical activity (36).”
BackgroundRetractedPoehlman, É. T., Toth, M., Ades, P. A., & Rosen, C. J. (1997) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1997.1160662.x · Cited by 128 · cited 4×
“sociated with weight gain, most studies do not reveal increases in BMI independent of normal aging (23, 24).”
BackgroundInfluentialRetractedGrundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154 · cited 1×
“Although syndrome X was initially coined by Gerald Reaven in 1988 (16), the features of the metabolic syndrome were first described by Vague (17) and have subsequently been called the insulin resistance syndrome, the central obesity syndrome, and the deadly quartet.”
BackgroundThe metabolic syndrome and total and cardiovascular disease mortality in middle-aged men
Lakka, H.-M. (2002) · JAMA · doi:10.1001/jama.288.21.2709 · Cited by 5,033 · cited 1×
“The metabolic syndrome may not be a single disease entity, but, rather, a constellation of closely related risk factors that together convey substantially increased cardiovascular risk after accounting for traditional CVD risk factors (12).”
BackgroundPark, Y.-W., Zhu, S., Palaniappan, L., Heshka, S., Carnethon, M. R., & Heymsfield, S. B. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.4.427 · Cited by 2,074 · cited 3×
“The metabolic syndrome is estimated to affect approximately 20–30% of the middle-aged population (10), and prevalence appears to be increasing in the U.”
BackgroundInfluentialChambless, L. E., Heiss, G., Folsom, A. R., Rosamond, W., Szklo, M., Sharrett, A. R., & Clegg, L. X. (1997) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009302 · Cited by 1,990
Thompson, S. G., Kienast, J., Pyke, S. D. M., Haverkate, F., & van de Loo, J. C. W. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503093321003 · Cited by 1,821
Cited by
Cornier, M.-A., Dabelea, D., Hernandez, T. L., Lindstrom, R. C., Steig, A. J., Stob, N. R., Van Pelt, R. E., Wang, H., & Eckel, R. H. (2008) · Endocrine Reviews · doi:10.1210/er.2008-0024 · Cited by 2,162
“Furthermore, it is unclear whether the menopause-related increases in insulin resistance and dyslipidemia are the result of estrogen deficiency directly or occur secondary to increases in abdominal adiposity (459).”
BackgroundThe role of estrogens in control of energy balance and glucose homeostasis
Mauvais-Jarvis, F., Clegg, D. J., & Hevener, A. L. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1055 · Cited by 1,329
“After menopause or OVX, a precipitous decline in insulin sensitivity parallels an increase in fat mass and elevations in circulating inflammatory markers, low-density lipoprotein (LDL), triglycerides, and fatty acids (6, 169, 170).”
BackgroundGrundy, S. M. (2011) · Atlas of Atherosclerosis and Metabolic Syndrome · doi:10.1007/978-1-4419-5839-6_1 · Cited by 1,223
Muka, T., Oliver-Williams, C., Kunutsor, S., Laven, J. S. E., Fauser, B. C. J. M., Chowdhury, R., Kavousi, M., & Franco, O. H. (2016) · JAMA Cardiology · doi:10.1001/jamacardio.2016.2415 · Cited by 826
Salpeter, S. R., Walsh, J. M. E., Ormiston, T. M., Greyber, E., Buckley, N. S., & Salpeter, E. E. (2006) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2005.00545.x · Cited by 640
Distinct Hypothalamic Neurons Mediate Estrogenic Effects on Energy Homeostasis and Reproduction
Xu, Y., Nedungadi, T. P., Zhu, L., Sobhani, N., Irani, B. G., Davis, K. E., Zhang, X., Zou, F., Gent, L. M., Hahner, L. D., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.08.009 · Cited by 597
“Lower levels of estrogens in postmenopausal women or in ovariectomized (OVX) animals are associated with obesity (Carr, 2003; Rogers et al., 2009).”
BackgroundEstrogen deficiency and the origin of obesity during menopause
Lizcano, F., & Guzmán, G. (2014) · BioMed Research International · doi:10.1155/2014/757461 · Cited by 586
“Estrogens deficiency enhances metabolic dysfunction predisposing to DM type 2, the metabolic syndrome, and cardiovascular diseases [31, 32].”
BackgroundMenopause-Associated Lipid Metabolic Disorders and Foods Beneficial for Postmenopausal Women
Ko, S.-H., & Kim, H.-S. (2020) · Nutrients · doi:10.3390/nu12010202 · Cited by 516
“Increased adiposity in postmenopausal women is significantly associated with hyperinsulinemia, which suggests that insulin resistance may be responsible for the development of the key features of postmenopausal dyslipidemia [69], obesity [70], metabolic syndrome [71], and type 2 diabetes [72].”
BackgroundEstrogen: A master regulator of bioenergetic systems in the brain and body
Rettberg, J. R., Yao, J., & Brinton, R. D. (2014) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2013.08.001 · Cited by 534
“Age-matched men tend to accumulate a greater amount of abdominal fat relative to premenopausal women, who accumulate fat in a metabolically healthier gluteo-femoral pattern that is promoted by estrogen (Carr, 2003; Krotkiewski et al., 1983).”
Obesity, Sleep Apnea, and Hypertension
Wolk, R., Shamsuzzaman, A. S. M., & Somers, V. K. (2003) · Hypertension · doi:10.1161/01.hyp.0000101686.98973.a3 · Cited by 532
Janssen, I. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.14.1568 · Cited by 514
“Menopausal status has been linked to some components of the MetS, but results are inconsistent.(18) Most cross-sectional studies show that postmenopausal women are more likely then premenopausal women to have higher triglyceride and lower high-density lipoprotein cholesterol (HDL-C) levels independent of age,(18) but…”
ResultEstrogen Regulation of Adiposity and Fuel Partitioning
D'Eon, T. M., Souza, S. C., Aronovitz, M., Obin, M. S., Fried, S. K., & Greenberg, A. S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m507339200 · Cited by 517
Changes in muscle mass and strength after menopause.
Maltais, M. L., Desroches, J., & Dionne, I. J. (2009) · PubMed · Cited by 590
Estradiol Regulates Brown Adipose Tissue Thermogenesis via Hypothalamic AMPK
Martínez de Morentin, P. B., González-García, I., Martins, L., Lage, R., Fernández-Mallo, D., Martínez-Sánchez, N., Ruíz-Pino, F., Liu, J., Morgan, D. A., Pinilla, L., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.03.031 · Cited by 451
“Estrogen replacement reverts this phenotype both in women and female rodents (Carr, 2003; Gao and Horvath, 2008; Rogers et al., 2009; Wren, 2009; Finan et al., 2012; Mauvais-Jarvis et al., 2013).”
BackgroundInnes, K. E., Bourguignon, C., & Taylor, A. G. (2005) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.18.6.491 · Cited by 425
Estrogens protect against high-fat diet-induced insulin resistance and glucose intolerance in mice
Riant, E., Waget, A., Cogo, H., Arnal, J.-F., Burcelin, R., & Gourdy, P. (2009) · Endocrinology · doi:10.1210/en.2008-0971 · Cited by 421
Fat Metabolism Links Germline Stem Cells and Longevity in C. elegans
Wang, M. C., O'Rourke, E. J., & Ruvkun, G. (2008) · Science · doi:10.1126/science.1162011 · Cited by 400
Menopause and sarcopenia: A potential role for sex hormones
Messier, V., Rabasa-Lhoret, R., Barbat-Artigas, S., Elisha, B., Karelis, A. D., & Aubertin-Leheudre, M. (2011) · Maturitas · doi:10.1016/j.maturitas.2011.01.014 · Cited by 397
“Accordingly, t has been reported that the decrease in estrogen contributes to he decrease in bone mass density, the redistribution of subcutaeous fat to the visceral area, the increased risk of cardiovascular isease and the decrease in quality of life [1].”
BackgroundEstrogen Receptors: Therapies Targeted to Receptor Subtypes
Nilsson, S., & Gustafsson, J.-Å. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2010.226 · Cited by 370
Mauvais-Jarvis, F., Manson, J. E., Stevenson, J. C., & Fonseca, V. A. (2017) · Endocrine Reviews · doi:10.1210/er.2016-1146 · Cited by 341
Mauvais-Jarvis, F. (2011) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2010.10.002 · Cited by 335
“N IH -PA Author M anuscript N IH -PA Author M anuscript menopause, in estrogen deficiency which predisposes to the metabolic syndrome and T2D [5].”
BackgroundInfluentialRibas, V., Nguyen, M. T. A., Henstridge, D. C., Nguyen, A.-K., Beaven, S. W., Watt, M. J., & Hevener, A. L. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00504.2009 · Cited by 309
“However, following menopause or ovariectomy this protection is lost, and a precipitous decline in insulin sensitivity coincides with increased fat mass and elevated circulating inflammatory markers [TNF , IL-6, and plasminogen activator inhibitor-1 (PAI-1)], LDL, triglycerides, and fatty acids (13, 58, 66).”
BackgroundFreedland, E. S. (2004) · Nutrition & Metabolism · doi:10.1186/1743-7075-1-12 · Cited by 298
“However, by age 70 the incidence of CHD is equal in men and women, suggesting that estrogen deficiency causes a rapid acceleration in CHD risk [133].”
International Journal of Collaborative Research on Internal Medicine & Public Health
Valdivia, J. R. M. (2021) · Journal of Womens Health Issues and Care · Cited by 300
Sex Differences in the Metabolic Syndrome: Implications for Cardiovascular Health in Women
Pradhan, A. D. (2014) · Clinical Chemistry · doi:10.1373/clinchem.2013.202549 · Cited by 283
Metabolic Actions of Estrogen Receptor Beta (ERβ) are Mediated by a Negative Cross-Talk with PPARγ
Foryst-Ludwig, A., Clemenz, M., Hohmann, S., Hartge, M., Sprang, C., Frost, N., Krikov, M., Bhanot, S., Barros, R., Morani, A., et al. (2008) · PLoS Genetics · doi:10.1371/journal.pgen.1000108 · Cited by 287
“In addition, lack of ER activation has been implicated in postmenopausal impairment of glucose and lipid metabolism, resulting in visceral fat distribution, insulin resistance and increased cardiovascular risk after menopause [9].”
BackgroundLee, C. G., Carr, M. C., Murdoch, S. J., Mitchell, E., Woods, N. F., Wener, M. H., Chandler, W. L., Boyko, E. J., & Brunzell, J. D. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0701 · Cited by 279
“The increase in visceral adiposity across the menopausal transition may result in the development of a proinflammatory adipokine changes (13).”
BackgroundSelf-citationGuo, Y., Warren Andersen, S., Shu, X.-O., Michailidou, K., Bolla, M. K., Wang, Q., Garcia-Closas, M., Milne, R. L., Schmidt, M. K., Chang-Claude, J., et al. (2016) · PLOS Medicine · doi:10.1371/journal.pmed.1002105 · Cited by 268
“Additionally, measured BMI in postmenopausal women may be a surrogate breast cancer risk factor for adiposity-related changes occurring near or after menopause, such as age-associated slowing metabolism and inflammation associated with increased abdominal fat [35].”
Turgeon, J. L., Carr, M. C., Maki, P. M., Mendelsohn, M. E., & Wise, P. M. (2006) · Endocrine Reviews · doi:10.1210/er.2005-0020 · Cited by 264
Self-citationSnyder, H. M., Asthana, S., Bain, L., Brinton, R., Craft, S., Dubal, D. B., Espeland, M. A., Gatz, M., Mielke, M. M., Raber, J., et al. (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.08.004 · Cited by 262
“Themetabolic syndrome, characterized by obesity, insulin resistance, hypertension, and dyslipidemia, has been linked to an increased risk of AD [85] and also increases during menopause [86].”
BackgroundClinical implications of bone marrow adiposity
Veldhuis‐Vlug, A. G., & Rosen, C. J. (2018) · Journal of Internal Medicine · doi:10.1111/joim.12718 · Cited by 242
Kaliannan, K., Robertson, R. C., Murphy, K., Stanton, C., Kang, C., Wang, B., Hao, L., Bhan, A. K., & Kang, J. X. (2018) · Microbiome · doi:10.1186/s40168-018-0587-0 · Cited by 253
Correlates of Circulating Androgens in Mid-Life Women: The Study of Women’s Health Across the Nation
Santoro, N., Torrens, J., Crawford, S., Allsworth, J. E., Finkelstein, J. S., Gold, E. B., Korenman, S., Lasley, W. L., Luborsky, J. L., McConnell, D., et al. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2063 · Cited by 246
“Whether large or increasing body size functions as a metabolic “trigger” that initiates changes in fuel economy at midlife has been proposed, but is at present, unproven (39, 40).”
BackgroundHutchison, A. L., Tavaglione, F., Romeo, S., & Charlton, M. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.08.030 · Cited by 250
The metabolic syndrome in cancer survivors
de Haas, E. C., Oosting, S. F., Lefrandt, J. D., Wolffenbuttel, B. H., Sleijfer, D. T., & Gietema, J. A. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70287-6 · Cited by 234
Sex hormones and their receptors regulate liver energy homeostasis
Shen, M., & Shi, H. (2015) · International Journal of Endocrinology · doi:10.1155/2015/294278 · Cited by 239
“menopausal women and the state of androgen deficiency as seen in aging men predispose older population to the metabolic syndrome and associated diabetes and cardiovascular diseases, indicating that sex hormones play important roles in regulating energy metabolism [5, 6].”
BackgroundFeng, Y., Hong, X., Wilker, E., Li, Z., Zhang, W., Jin, D., Liu, X., Zang, T., Xu, X., & Xu, X. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.06.016 · Cited by 236
“Natural menopause is associated with an increased central adiposity [23–25] and it contributes to the worsening of lipid profile in post-menopausal women [16].”
BackgroundResultSarcopenia and menopause: The role of estradiol
Geraci, A., Calvani, R., Ferri, E., Marzetti, E., Arosio, B., & Cesari, M. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.682012 · Cited by 238
“One of the most striking phenomena marking women’s aging process is menopause, which brings about hormonal changes (4, 5) and, in particular, estradiol levels.”
BackgroundJanssen, I., Powell, L. H., Kazlauskaite, R., & Dugan, S. A. (2010) · Obesity · doi:10.1038/oby.2009.251 · Cited by 235
Gender Aspects of the Role of the Metabolic Syndrome as a Risk Factor for Cardiovascular Disease
Regitz-Zagrosek, V., Lehmkuhl, E., & Mahmoodzadeh, S. (2007) · Gender Medicine · doi:10.1016/s1550-8579(07)80056-8 · Cited by 228
The diversity of sex steroid action: regulation of metabolism by estrogen signaling
Faulds, M. H., Zhao, C., Dahlman-Wright, K., & Gustafsson, J.-Å. (2012) · Journal of Endocrinology · doi:10.1530/joe-11-0044 · Cited by 230
“The onset of menopause is associated with several metabolic changes and postmenopausal women fall into the same risk category as men for development of atherosclerosis and myocardial infarction (Carr 2003).”
BackgroundAbdulnour, J., Doucet, É., Brochu, M., Lavoie, J.-M., Strychar, I., Rabasa-Lhoret, R., & Prud’homme, D. (2012) · Menopause · doi:10.1097/gme.0b013e318240f6f3 · Cited by 229
“Finally, knowing that the duration of the postmenopausal period is one of the determinants of cardiometabolic profile, a longer follow-up may have been helpful to observe metabolic deteriorations in our sample of healthy nonobese women.(49)”
BackgroundKarvonen-Gutierrez, C., & Kim, C. (2016) · Healthcare · doi:10.3390/healthcare4030042 · Cited by 188
“Menopausal increases in VAT independent of age have been confirmed in cross-sectional [112–115] and longitudinal studies [89,92,93,107,116].”
ResultOxenkrug, G. F. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05356.x · Cited by 221
Impaired kisspeptin signaling decreases metabolism and promotes glucose intolerance and obesity
Tolson, K. P., Garcia, C., Yen, S., Simonds, S., Stefanidis, A., Lawrence, A., Smith, J. T., & Kauffman, A. S. (2014) · Journal of Clinical Investigation · doi:10.1172/jci71075 · Cited by 194
“Long-term absent estrogen, as in ovariectomized (OVX) or post-menopausal females, can increase BW (20, 21).”
Sharma, G., Hu, C., Brigman, J. L., Zhu, G., Hathaway, H. J., & Prossnitz, E. R. (2013) · Endocrinology · doi:10.1210/en.2013-1357 · Cited by 210
“Parallel observations in humans reveal that postmenopausal women are more prone to visceral weight gain and metabolic dysfunction (7, 8).”
BackgroundEstrogen: An Emerging Regulator of Insulin Action and Mitochondrial Function
Gupte, A. A., Pownall, H. J., & Hamilton, D. J. (2015) · Journal of Diabetes Research · doi:10.1155/2015/916585 · Cited by 198
“Together these changes increase the risk of nonalcoholic steatohepatitis, type 2 diabetes, and cardiovascular disease and its complications [1].”
BackgroundMehta, L. S., Velarde, G. P., Lewey, J., Sharma, G., Bond, R. M., Navas-Acien, A., Fretts, A. M., Magwood, G. S., Yang, E., Blumenthal, R. S., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001139 · Cited by 181
Physical activity, symptoms, esteem, and life satisfaction during menopause
Elavsky, S., & McAuley, E. (2005) · Maturitas · doi:10.1016/j.maturitas.2004.07.014 · Cited by 194
Menopause is an independent predictor of metabolic syndrome in Iranian women
Eshtiaghi, R., Esteghamati, A., & Nakhjavani, M. (2010) · Maturitas · doi:10.1016/j.maturitas.2009.11.004 · Cited by 195
“Menopausal tatus has been linked to some components of theMetS, but results re inconsistent [4].”
ResultThe Effect of Menopause on the Metabolic Syndrome Among Korean Women
Kim, H. M., Park, J., Ryu, S. Y., & Kim, J. (2007) · Diabetes Care · doi:10.2337/dc06-1400 · Cited by 195
“However, not all studies (28,30) agree with this conclusion.”
BackgroundResultProgression of Metabolic Syndrome Severity During the Menopausal Transition
Gurka, M. J., Vishnu, A., Santen, R. J., & DeBoer, M. D. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.116.003609 · Cited by 182
“Many have hypothesized that this higher CVD risk is related to an increase in the metabolic syndrome (MetS) during the menopausal transition, beyond what is seen from aging alone.(3) Cross-sectional studies have demonstrated that compared with premenopausal women, postmenopausal women have significantly more visceral…”
BackgroundObesity in menopause - our negligence or an unfortunate inevitability
Kozakowski, J., Gietka-Czernel, M., Leszczyńska, D., & Majos, A. (2017) · Menopausal Review · doi:10.5114/pm.2017.68594 · Cited by 189
“On the other hand, many authors have evidenced the existence of such relationship, although usually the study groups were not matched for BMI or waist circumference [11, 12].”
BackgroundEstrogen Replacement Reverses the Hepatic Steatosis Phenotype in the Male Aromatase Knockout Mouse
Hewitt, K. N., Pratis, K., Jones, M. E. E., & Simpson, E. R. (2004) · Endocrinology · doi:10.1210/en.2003-1369 · Cited by 188
“Menopausal women have a reduction in circulating estrogen levels and this coincides with a shift in body fat from the gluteal to the abdominal region, thus linking lack of estrogen to central obesity (3).”
BackgroundHealth Promoting Properties of Bee Royal Jelly: Food of the Queens
Collazo, N., Carpena, M., Nuñez-Estevez, B., Otero, P., Simal-Gandara, J., & Prieto, M. A. (2021) · Nutrients · doi:10.3390/nu13020543 · Cited by 173
Genistein in the Metabolic Syndrome: Results of a Randomized Clinical Trial
Squadrito, F., Marini, H., Bitto, A., Altavilla, D., Polito, F., Adamo, E. B., D'Anna, R., Arcoraci, V., Burnett, B. P., Minutoli, L., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1180 · Cited by 179
Pathophysiological dilemmas of lipedema
Szél, E., Kemény, L., Groma, G., & Szolnoky, G. (2014) · Medical Hypotheses · doi:10.1016/j.mehy.2014.08.011 · Cited by 173
“As women reach menopause and the blood estrogen level starts declining, alterations in energy homeostasis leading to increased intraabdominal body fat accumulation also occur [38].”
BackgroundJoon Cho, G., Hyun Lee, J., Tae Park, H., Ho Shin, J., Cheol Hong, S., Kim, T., Young Hur, J., Wan Lee, K., Kyun Park, Y., & Haeng Kim, S. (2008) · Menopause · doi:10.1097/gme.0b013e3181559860 · Cited by 182
“Body fat distribution changes after menopause.(5) Many studies showed that the menopausal transition is associated with a preferential increase in abdominal adiposity and that postmenopausal women have a significantly higher prevalence of abdominal obesity, using the same definition of abdominal obesity as used in thi…”
BackgroundMethodKristensen, M., Toubro, S., Jensen, M. G., Ross, A. B., Riboldi, G., Petronio, M., Bgel, S., Tetens, I., & Astrup, A. (2012) · The Journal of Nutrition · doi:10.3945/jn.111.142315 · Cited by 179
“Thus, there is increased risk of developing CVD among postmenopausal women (42).”
BackgroundSex differences in type 2 diabetes: focus on disease course and outcomes
Arnetz, L., Rajamand Ekberg, N., & Alvarsson, M. (2014) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s51301 · Cited by 175
“epidemiology Women are relatively protected from CVD before menopause,(124) while after menopause the risk of CVD increases to levels equal to those in men.(68,125) Despite this, it”
BackgroundNorris, L. E., Collene, A. L., Asp, M. L., Hsu, J. C., Liu, L.-F., Richardson, J. R., Li, D., Bell, D., Osei, K., Jackson, R. D., et al. (2009) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.27371 · Cited by 171
“These alterations in body composition increase the risk of developing metabolic syndrome (3).”
BackgroundHIV Infection, Drug Use, and Onset of Natural Menopause
Schoenbaum, E. E., Hartel, D., Lo, Y., Howard, A. A., Floris-Moore, M., Arnsten, J. H., & Santoro, N. (2005) · Clinical Infectious Diseases · doi:10.1086/497270 · Cited by 167
The regulation of adipose tissue health by estrogens
Steiner, B. M., & Berry, D. C. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.889923 · Cited by 171
Menopause and diabetes: EMAS clinical guide
Słopień, R., Wender-Ożegowska, E., Rogowicz‐Frontczak, A., Męczekalski, B., Zozulińska‐Ziółkiewicz, D., Jaremek, J. D., Cano, A., Chedraui, P. A., Goulis, D. G., Lopès, P., et al. (2018) · Maturitas · doi:10.1016/j.maturitas.2018.08.009 · Cited by 168
“Whether these changes are independent of ageing itself has been a matter of debate [4].”
BackgroundFSH regulates fat accumulation and redistribution in aging through the Gαi/Ca 2+ /CREB pathway
Liu, X., Chan, H. C., Ding, G., Cai, J., Song, Y., Wang, T., Zhang, D., Chen, H., Yu, M. K., Wu, Y., et al. (2015) · Aging Cell · doi:10.1111/acel.12331 · Cited by 164
“The accumulation of visceral (abdominal) adiposity in aging populations may be accompanied with insulin resistance, hypertension and dyslipidemia [hypertriglyceridemia, reduced high-density lipoprotein and low-density lipoprotein (LDL) particles] (Carr, 2003); in turn, risks of metabolic syndrome-related diseases, suc…”
BackgroundMayneris‐Perxachs, J., Guerendiain, M., Castellote, A. I., Estruch, R., Covas, M. I., Fitó, M., Salas‐Salvadó, J., Martínez‐González, M. Á., Arós, F., Lamuela-Raventós, R. M., et al. (2013) · Clinical Nutrition · doi:10.1016/j.clnu.2013.03.001 · Cited by 164
Genetic rescue of nonclassical ERα signaling normalizes energy balance in obese Erα-null mutant mice
Park, C. J., Zhao, Z., Glidewell-Kenney, C., Lazic, M., Chambon, P., Krust, A., Weiss, J., Clegg, D. J., Dunaif, A., Jameson, J. L., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci41702 · Cited by 162
“Estrogen deficiency at menopause is associated with an increased probability of obesity as well as increased risk for the development of type 2 diabetes (2).”
BackgroundA midlife stroke surge among women in the United States
Towfighi, A., Saver, J. L., Engelhardt, R., & Ovbiagele, B. (2007) · Neurology · doi:10.1212/01.wnl.0000268491.89956.c2 · Cited by 164
Rachoń, D., & Teede, H. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.09.026 · Cited by 161
“These hormonal changes have been associated with the development of several chronic conditions including the emergence of the metabolic syndrome (MS) and its consequences such as T2DM and CVD (Carr, 2003).”
BackgroundThe metabolic syndrome in women
Bentley–Lewis, R., Koruda, K., & Seely, E. W. (2007) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0616 · Cited by 174
Correa, S. M., Newstrom, D. W., Warne, J. P., Flandin, P., Cheung, C. C., Lin-Moore, A. T., Pierce, A. A., Xu, A. W., Rubenstein, J. L. R., & Ingraham, H. A. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.12.011 · Cited by 159
Nonalcoholic Fatty Liver Disease in Women
Suzuki, A., & Abdelmalek, M. F. (2009) · Women s Health · doi:10.2217/17455057.5.2.191 · Cited by 170
Curtis, P. J., Kroon, P. A., Hollands, W. J., Walls, R., Jenkins, G., Kay, C. D., & Cassidy, A. (2009) · Journal of Nutrition · doi:10.3945/jn.109.113126 · Cited by 155
Gender differences in the cardiovascular effects of sex hormones
Vitale, C., Fini, M., Speziale, G., & Chierchia, S. L. (2010) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2010.00817.x · Cited by 176
Influence of menopause on diabetes and diabetes risk
Szmuilowicz, E. D., Stuenkel, C. A., & Seely, E. W. (2009) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2009.166 · Cited by 152
“Metabolic effects Changes in body composition Women commonly experience weight gain during the perimenopausal years; however, such weight gain is thought to be a result of aging as opposed to menopausal status per se”
Lung function, respiratory symptoms, and the menopausal transition
Real, F. G., Svanes, C., Omenaas, E. R., Antó, J. M., Plana, E., Jarvis, D., Janson, C., Neukirch, F., Zemp, E., Dratva, J., et al. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.08.057 · Cited by 153
“cardiovascular diseases.(19,20) Furthermore, with the appearance of climacteric symptoms, exogenous hormones are widely used; these hormones interact with a changing preexisting hormonal and metabolic status.”
BackgroundWomen’s health in menopause with a focus on hypertension
Maas, A. H. E. M., & Franke, H. R. (2009) · Netherlands Heart Journal · doi:10.1007/bf03086220 · Cited by 167
Pérez-López, F. R., Chedraui, P. A., Gilbert, J. J., & Pérez‐Roncero, G. R. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.06.032 · Cited by 169
“In addition, perimenopausal metabolic changes seen in longitudinal studies are reminiscent of the METS (154).”
BackgroundMenopause is Associated with Accelerated Lung Function Decline
Triebner, K., Matulonga, B., Johannessen, A., Suske, S., Benediktsdóttir, B., Demoly, P. M., Dharmage, S. C., Franklin, K. A., García‐Aymerich, J., Blanco, J. A. G., et al. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201605-0968oc · Cited by 151
Lipid profile differences during menopause: a review with meta-analysis
Ambikairajah, A., Walsh, E., & Cherbuin, N. (2019) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000001403 · Cited by 151
The Roles of Androgens in Humans: Biology, Metabolic Regulation and Health
Alemany, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911952 · Cited by 174
Ovarian Hormone Status and Abdominal Visceral Adipose Tissue Metabolism
Tchernof, A., Desmeules, A., Richard, C., Laberge, P. Y., Daris, M., Mailloux, J. R., Rhéaume, C., & Dupont, P. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031561 · Cited by 151
Ke, J., Kliewer, K., Hamad, E. M., Cole, R. M., Powell, K. A., Andridge, R., Straka, S. R., Yee, L. D., & Belury, M. A. (2015) · Nutrition & Metabolism · doi:10.1186/1743-7075-12-1 · Cited by 146
“We report here that OVX mice exhibited metabolic disturbances expected with estrogen deficiency including elevated fasting glucose and obesity [3,26,31].”
BackgroundResultHealy, L., Ryan, A. M., Carroll, P. A., Ennis, D. P., Crowley, V., Boyle, T., Kennedy, M. J., Connolly, E., & Reynolds, J. V. (2010) · Clinical Oncology · doi:10.1016/j.clon.2010.02.001 · Cited by 145
“The fact that menopause induces a redistribution of fat mass leading to increased abdominal obesity and affects lipid metabolism [11], possibly beginning in the years preceding the actual time of menopause, may explain the increased risk of metabolic syndrome in postmenopausal women [12,13].”
Background‘Endocrine NAFLD’ a hormonocentric perspective of nonalcoholic fatty liver disease pathogenesis
Lonardo, A., Carani, C., Carulli, N., & Loria, P. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.03.005 · Cited by 149
“[96] Carr MC.”
BackgroundCentral nervous control of energy and glucose balance: focus on the central melanocortin system
Xu, Y., Elmquist, J. K., & Fukuda, M. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06248.x · Cited by 154
4-vinylcyclohexene diepoxide: a model chemical for ovotoxicity
Mark-Kappeler, C. J., & Hoyer, P. B. (2012) · Systems Biology in Reproductive Medicine · doi:10.3109/19396368.2011.648820 · Cited by 138
“Early menopause would increase the risk of developing such menopause-associated disorders as cardiovascular disease, osteoporosis, metabolic syndrome, ovarian cancer, Alzheimer’s disease, and depression [Sowers et al. 1995; Carr 2003; Fernandez et al. 1998; Vanderhyden 2005; Waring 1999].”
BackgroundCodes, L., Asselah, T., Cazals-Hatem, D., Tubach, F., Vidaud, D., Paraná, R., Bedossa, P., Valla, D., & Marcellin, P. (2007) · Gut · doi:10.1136/gut.2006.101931 · Cited by 137
“The prevalence of the metabolic syndrome increases with the menopause and may partially explain the apparent acceleration in cardiovascular disease after the menopause.”
BackgroundThe interplay between diabetes mellitus and menopause: clinical implications
Lambrinoudaki, I. V., Paschou, S. Α., Armeni, E., & Goulis, D. G. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00708-0 · Cited by 152
Oestrogen engages brain MC4R signalling to drive physical activity in female mice
Krause, W. C., Rodríguez, R., Gegenhuber, B., Matharu, N. K., Rodriguez, A. N., Padilla-Roger, A. M., Toma, K., Herber, C. B., Correa, S. M., Duan, X., et al. (2021) · Nature · doi:10.1038/s41586-021-04010-3 · Cited by 141
Lower-Body Adiposity and Metabolic Protection in Postmenopausal Women
Pelt, R. E. V., Jankowski, C. M., Gozansky, W. S., Schwartz, R. S., & Kohrt, W. M. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1764 · Cited by 132
“Perhaps not coincidentally, both abdominal fat accumulation and the incidence of CVD accelerate in women after the menopause (2,3).”
BackgroundHormone replacement therapy in young women with surgical primary ovarian insufficiency
Sarrel, P. M., Sullivan, S. D., & Nelson, L. M. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.09.018 · Cited by 131
Health issues for menopausal women: The top 11 conditions have common solutions
van Dijk, G. M., Kavousi, M., Troup, J., & Franco, O. H. (2014) · Maturitas · doi:10.1016/j.maturitas.2014.09.013 · Cited by 138
“Estrogen levels before menopause might mask a genetic predisposition for metabolic risk factors associated with DM, such as insulin resistance with small, dense low-density lipoprotein (LDL) and elevated PAI-1 [6].”
BackgroundInfluentialIncidence of diabetes among postmenopausal breast cancer survivors
Lipscombe, L. L., Chan, W. W., Yun, L., Austin, P. C., Anderson, G. M., & Rochon, P. A. (2012) · Diabetologia · doi:10.1007/s00125-012-2793-9 · Cited by 128
“Oestrogen suppression as a result of chemotherapy may further promote diabetes; however, this factor may be less of an issue within the postmenopausal population [8, 9, 19].”
BackgroundTargeting sphingosine-1-phosphate lyase as an anabolic therapy for bone loss
Weske, S., Vaidya, M., Reese, A., Lipinski, K. V. W., Keul, P., Bayer, J. K., Fischer, J. W., Flögel, U., Nelsen, J., Epple, M., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0005-y · Cited by 127
Hallajzadeh, J., Khoramdad, M., Izadi, N., Karamzad, N., Almasi‐Hashiani, A., Ayubi, E., Qorbani, M., Pakzad, R., Hasanzadeh, A., Sullman, M. J. M., et al. (2018) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000001136 · Cited by 127
Childhood trauma and metabolic syndrome in men and women
Lee, C., Tsenkova, V., & Carr, D. (2014) · Social Science & Medicine · doi:10.1016/j.socscimed.2014.01.017 · Cited by 125
“, estrogen) cause women to have lower blood pressure and less abdominal fat than men, which may help delay the onset of MetS until menopause; the gap between men and women narrows and even reverses after menopause (Carr, 2003).”
InfluentialHandgraaf, S., Riant, É., Fabre, A., Waget, A., Burcelin, R., Lière, P., Krust, A., Chambon, P., Arnal, J., & Gourdy, P. (2013) · Diabetes · doi:10.2337/db13-0282 · Cited by 133
“Estrogens are now recognized as key regulators of energy balance and glucose homeostasis since estrogen deficiency promotes visceral adiposity and insulin resistance in menopausal women, resulting in an increased risk of type 2 diabetes (1).”
Thyroid stimulating hormone is associated with metabolic syndrome in euthyroid postmenopausal women
Park, H. T., Cho, G. J., Ahn, K. H., Shin, J., Hong, S., Kim, T., Hur, J. Y., Kim, Y. T., Lee, K. W., & Kim, S. H. (2009) · Maturitas · doi:10.1016/j.maturitas.2009.01.007 · Cited by 123
Royer, M., Castelo‐Branco, C., Blümel, J. E., Chedraui, P. A., Danckers, L., Bencosme, A., Navarro, D., Vallejo, S., Espinoza, M. T., Gómez, G., et al. (2007) · Climacteric · doi:10.1080/13697130701258895 · Cited by 122
Metadata
- Authors
- Carr, M. C.
- Affiliations
- University of Washington (US)
- Corresponding author
- Carr, Molly C.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2003-06
- Volume
- 88
- Issue
- 6
- Pages
- 2404-2411
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2123609879
- Cited by
- 1,449
- References
- 84
- Citations by year
- 2026: 54 · 2025: 64 · 2024: 55 · 2023: 67 · 2022: 69 · 2021: 69 · 2020: 65 · 2019: 67 · 2018: 86 · 2017: 61 · 2016: 97 · 2015: 91 · 2014: 79 · 2013: 84 · 2012: 86
- FWCI
- 18.06
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Public Health Service
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Keywords
- metabolic syndrome, menopause, estrogen deficiency, ovarian failure, abdominal obesity, insulin resistance, dyslipidemia, cardiovascular risk, postmenopausal women, atherogenic lipid profile, small dense LDL, glucose metabolism
- MeSH terms
- Body Composition, Cardiovascular Diseases, Female, Humans, Menopause, Risk Factors, Prevalence, Metabolic Syndrome, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.